Concepedia

Anne Cooper

AC

13

Publications

804

Citations

12

H-Index

1988

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

Loughborough University

AstraZeneca (Sweden)

University of California, Davis

Emory University

Anne Cooper is an author at AstraZeneca (United Kingdom) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

1988–2013

13

Publications

13

Detection of Autoantibodies to Recombinant Mitochondrial Proteins in Patients with Primary Biliary Cirrhosis

Judy Van de Water, Anne Cooper, Charles D. Surh et al. · New England Journal of Medicine · 1989 · 203 citations

Differential Multidrug Resistance-Associated Protein 1 through 6 Isoform Expression and Function in Human Intestinal Epithelial Caco-2 Cells

Hannah M. Prime-Chapman, Richard A. Fearn, Anne Cooper et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 141 citations

Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors

Andrew Baxter, Steve Brough, Anne Cooper et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 90 citations

, , +11

A longitudinal pilot proton MRS investigation of the manic and euthymic states of bipolar disorder

Roscoe O. Brady, Anne Cooper, John Eric Jensen et al. · Translational Psychiatry · 2012 · 72 citations · Full text

, , +19

The predominance of IgG3 and IgM isotype antimitochondrial autoantibodies against recombinant fused mitochondrial polypeptide in patients with primary biliary cirrhosis

Charles D. Surh, Anne Cooper, Ross L. Coppel et al. · Hepatology · 1988 · 69 citations · Full text

Rows per page

1–5 of 13